Scarica l'app Stockscreener
11.63
1.61%
-0.19
Dopo l'orario di chiusura:
12.18
0.55
+4.73%
Precedente Chiudi:
$11.82
Aprire:
$11.73
Volume 24 ore:
8.46M
Relative Volume:
1.74
Capitalizzazione di mercato:
$5.75B
Reddito:
$4.45B
Utile/perdita netta:
$205.00M
Rapporto P/E:
-58.15
EPS:
-0.2
Flusso di cassa netto:
$372.00M
1 W Prestazione:
-3.88%
1M Prestazione:
-13.47%
6M Prestazione:
-36.10%
1 anno Prestazione:
-16.99%
Intervallo 1D:
$11.63
$12.19
Intervallo di 1 settimana:
$11.50
$12.47
Portata 52W:
$11.40
$18.80
Elanco Animal Health Inc Stock (ELAN) Company Profile
Nome
Elanco Animal Health Inc
Settore
Telefono
877-352-6261
Indirizzo
2500 INNOVATION WAY, GREENFIELD
Confronta ELAN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
11.63 | 5.75B | 4.45B | 205.00M | 372.00M | 0.40 |
|
ZTS
Zoetis Inc
|
164.84 | 74.37B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.69 | 43.81B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.10 | 41.53B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
22.09 | 25.03B | 16.77B | -959.00M | 1.37B | -0.85 |
|
VTRS
Viatris Inc
|
12.52 | 14.94B | 15.05B | -883.30M | 1.89B | -0.74 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-09 | Iniziato | UBS | Buy |
| 2024-12-02 | Iniziato | Leerink Partners | Market Perform |
| 2024-09-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | Aggiornamento | Stifel | Hold → Buy |
| 2023-12-19 | Iniziato | Jefferies | Buy |
| 2023-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | Iniziato | Exane BNP Paribas | Outperform |
| 2023-04-20 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2022-08-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-07-21 | Downgrade | Goldman | Buy → Sell |
| 2022-07-12 | Iniziato | Piper Sandler | Neutral |
| 2021-11-18 | Iniziato | Morgan Stanley | Overweight |
| 2021-10-28 | Downgrade | Stifel | Buy → Hold |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-06-15 | Aggiornamento | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2021-05-11 | Aggiornamento | Gabelli & Co | Hold → Buy |
| 2021-04-15 | Iniziato | Stifel | Buy |
| 2021-03-22 | Downgrade | Gabelli & Co | Buy → Hold |
| 2021-02-26 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | Downgrade | Argus | Buy → Hold |
| 2020-11-09 | Downgrade | Barclays | Overweight → Underweight |
| 2020-08-20 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | Ripresa | Credit Suisse | Neutral |
| 2020-08-04 | Ripresa | Goldman | Buy |
| 2020-07-27 | Downgrade | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | Iniziato | Raymond James | Mkt Perform |
| 2019-12-19 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | Iniziato | Barclays | Overweight |
| 2019-08-26 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | Aggiornamento | UBS | Sell → Neutral |
| 2019-05-23 | Iniziato | Guggenheim | Neutral |
| 2019-03-18 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | Ripresa | Morgan Stanley | Equal-Weight |
| 2019-02-12 | Iniziato | William Blair | Mkt Perform |
| 2019-01-23 | Iniziato | UBS | Sell |
| 2019-01-15 | Iniziato | Argus | Buy |
| 2018-10-15 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Elanco Animal Health Inc Borsa (ELAN) Ultime notizie
Stifel Financial Corp Has $1.65 Million Holdings in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Canine Atopic Dermatitis Market Projected for Significant Growth (2024-2031) | Zoetis, Elanco, Virbac. - openPR
Elanco Confirms Date and Conference Call for Third Quarter 2024 Financial Results Announcement - Kilgore News Herald
Elanco to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - PR Newswire
Elanco Acquires Speke Contract Manufacturing Facility, Securing Key Supply Chain - The Eastern Progress Online
US FDA approves Elanco's treatment for parasitic infections in dogs - AOL
Elanco Animal Health Incorporated (NYSE:ELAN) Shares Bought by Geode Capital Management LLC - MarketBeat
Elanco Animal Health Incorporated (NYSE:ELAN) Receives $16.75 Consensus Target Price from Analysts - MarketBeat
Elanco Animal Health's SWOT analysis: stock outlook amid product launches, challenges - Investing.com Canada
2024 veterinary news in review: #17 - DVM 360
Animal Healthcare Market Next Big Thing | Big Giants Elanco, Bayer, Phibro Animal Health - openPR
Elanco Animal Health Incorporated's (NYSE:ELAN) Business And Shares Still Trailing The Industry - Simply Wall St
ELAN Investors Have Opportunity to Lead Elanco Animal Health Incorporated Securities Fraud Lawsuit with the Schall Law Firm - The Eastern Progress Online
Elanco Animal Health Incorporated Sued for Securities Law ViolationsInvestors Should Contact The Gross Law Firm Before December 6, 2024 to Discuss Your RightsELAN - The Eastern Progress Online
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elanco Animal Health - The Eastern Progress Online
Wellington Management Group LLP Purchases 646,522 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
ELAN Class Action News: Robbins LLP Reminds Investors of the Quickly Approaching Lead Plaintiff Deadline in the Elanco Animal Health Incorporated Class Action - The Eastern Progress Online
UBS Initiates Coverage of Elanco Animal Health (ELAN) with Buy Recommendation - MSN
NYSE: ELAN Lawsuit Alert: Investors who lost money with Elanco Animal Health Incorporated shares should contact the Shareholders Foundation - PR Newswire
Elanco Animal Health (NYSE:ELAN) Earns Buy Rating from Analysts at UBS Group - MarketBeat
Veterinary Oncology Market Generated Opportunities, Future - openPR
Quantinno Capital Management LP Acquires 100,183 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Elanco Animal Health Incorporated (NYSE:ELAN) Shares Sold by Fmr LLC - MarketBeat
Point72 Asset Management L.P. Purchases Shares of 1,341,582 Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
ELAN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Elanco Animal Health Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
ELAN Deadline Today: Rosen Law Firm Urges Elanco Animal Health Incorporated (NYSE: ELAN) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elanco Animal Health - Business Wire
Class Action Filed Against Elanco Animal Health Incorporated (ELAN)December 6, 2024 Deadline to JoinContact Levi & Korsinsky - Morningstar
Veterinary Medicine Market Expected to Surge by 2031 Elanco - openPR
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 44,370 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
ELAN Deadline: ELAN Investors Have Opportunity to Lead Elanco Animal Health Incorporated Lawsuit - PR Newswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates C - GuruFocus.com
Shareholders that lost money on Elanco Animal Health Incorporated(ELAN) Urged to Join Class ActionContact The Gross Law Firm to Learn More - PR Newswire
Edgestream Partners L.P. Acquires Shares of 62,958 Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Elanco Animal Health Incorporated (NYSE:ELAN) Shares Purchased by BNP Paribas Financial Markets - MarketBeat
ELAN Investors Have Opportunity to Lead Elanco Animal Health Inc - GuruFocus.com
Elanco Animal Health Inc (ELAN) Shares Gap Down to $12.74 on Dec 3 - GuruFocus.com
What is Leerink Partnrs' Forecast for ELAN FY2024 Earnings? - MarketBeat
ELAN CLASS ACTION: A Securities Fraud Class Action Lawsuit - GlobeNewswire
Top 3 Health Care Stocks That Could Blast Off In December - Benzinga
Director Garcia Art A was granted 18,169 shares, increasing direct ownership by 29% to 80,964 units (SEC Form 4) - Quantisnow
Elanco Animal Health Inc Azioni (ELAN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.89%
1.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):